Progesterone Is Being Prescribed to Men. Here's Why That's a Problem.

Some men on hormone therapy aren't getting better. Their energy is flat. Their libido is low. Their labs look reasonable on paper. But they don't feel optimized — and when you look at their protocol, one thing stands out.

Progesterone.

It's in more male protocols than it should be. Some providers include it for "balance." Some offer it as a sleep aid. The intentions may be reasonable. The biology is not.

Progesterone is a powerful hormone. In female physiology, it's essential — stabilizing, protective, deeply beneficial. But the female body evolved to receive it. The male body did not. And the research on what progesterone actually does inside a man makes that distinction impossible to ignore.

Problem 1: Progesterone Drives Inflammation in Men

Start with the data.

A 2005 study published in the Journal of Clinical Endocrinology & Metabolism examined the relationship between progesterone and inflammation in healthy men — not sick men, not men on medications. Healthy men, aged 20 to 50.

In the first arm, researchers measured endogenous progesterone levels and compared them against a panel of inflammation markers. The findings were unambiguous. Higher progesterone tracked directly with elevated IL-6, C-reactive protein, VCAM-1, E-selectin, and neutrophil counts. Every marker moved in the wrong direction as progesterone rose.

The second arm was a controlled trial. Men who received an exogenous progestin alongside testosterone saw IL-6 spike sharply. Anti-inflammatory IL-10 — the body's counter-regulatory response — dropped significantly. Men receiving testosterone alone showed the opposite: their inflammatory profile improved.

The authors concluded directly: progesterone corresponds to an inflammatory profile in healthy men, and exogenous progestins amplify that effect.

This is not a theoretical concern. IL-6 and CRP are not obscure research endpoints. They are markers of systemic inflammation — the same inflammatory burden that drives cardiovascular disease, metabolic dysfunction, insulin resistance, and accelerated biological aging. A protocol increasing that burden isn't optimizing anything. It is working against the very outcomes it claims to support.

Problem 2: Progestins Tell the Male Hormonal Axis to Shut Down

The second problem runs deeper.

Progestins suppress LH and FSH — the gonadotropins that drive endogenous testosterone production. This isn't a side effect. It's a primary pharmacological mechanism. It's exactly why progestins have been studied for decades in male hormonal contraception research: combined with testosterone, they drive pituitary output toward zero and shut down spermatogenesis. This has been demonstrated in clinical trials, published in peer-reviewed literature, and replicated across multiple progestin compounds.

What this means in the context of hormone optimization: adding a progestogen to a male protocol means adding a compound that pharmacologically signals the hypothalamic-pituitary axis to stand down. Less LH. Less FSH. Less endogenous testosterone stimulus.

A man on exogenous testosterone may not feel this acutely — his levels are being replaced. But the axis-level interference doesn't disappear. You are running an optimization protocol with one hand while using the other to suppress the system that protocol depends on.

There is no legitimate optimization rationale for this in men.

Problem 3: This Is the Same Compound Class Used to Eliminate Male Sexual Function

Here is what makes the clinical picture impossible to rationalize.

Progestogens — specifically medroxyprogesterone acetate — are used clinically in the management of male sex offenders. The therapeutic goal is the deliberate suppression of male sexual function. The published literature documents the effects with precision: reduced libido, diminished erectile capacity, decreased sexual arousal, blunted drive.

That is not a side effect. That is the intended mechanism. It is the reason it works for that purpose.

Now consider the population walking into hormone optimization clinics. Men presenting with low libido. Men with erectile dysfunction. Men who feel flat, disengaged, sexually underperforming. These are the exact symptoms that bring people through the door.

And some of those men are being given a compound class whose documented mechanism in male physiology is the suppression of exactly those functions.

That's not an overstatement. It is a direct reading of the published clinical literature. The compound being offered as part of the solution shares a mechanism with drugs used deliberately to eliminate male sexual function.

Why the Confusion Persists

Progesterone has a genuinely impressive clinical profile — in women.

Better sleep. Cardiovascular protection. Mood stability. Endometrial balance. The evidence base in female BHRT is strong. The benefits are real.

The error is transferring that profile across a physiological boundary where it doesn't apply. Steroid hormones don't work the same way in every body. The response depends entirely on the cellular environment receiving the signal: which receptors are expressed, how they're wired, what downstream pathways activate.

Men and women do not run the same hormonal operating system. Progesterone belongs in female physiology. The data on what it does in male physiology — inflammation, gonadotropin suppression, sexual dysfunction — is not ambiguous.

What I See in Practice

When a man comes in not responding to what should be a well-constructed protocol, progesterone is one of the first things I look at.

The presentation is often subtle. Energy that should be better by now. Sleep that hasn't improved the way it should. Libido that isn't where it needs to be. Inflammatory markers on labs that don't have a clean explanation.

Consider a patient in his mid-50s: active, otherwise healthy, two years into testosterone therapy. Testosterone levels optimized. Thyroid addressed. CRP still elevated. Energy inconsistent. His prior protocol included progesterone — added by a previous provider for sleep support.

Removing the progesterone and restructuring the protocol around compounds appropriate for male physiology: CRP normalized. Sleep improved. Energy stabilized. Nothing dramatic was added. Something that didn't belong was removed.

That is frequently how optimization actually works. It isn't always about adding more. It's about identifying what's creating friction and eliminating it.

What Belongs in a Male Hormone Protocol

A well-constructed male protocol is built around what the male endocrine system is designed to use.

Testosterone optimization — not just reaching a reference range, but achieving the balance of free testosterone, total testosterone, estradiol, and SHBG that produces genuine clinical results.

Thyroid — not just TSH, but Free T3, Free T4, and the conversion pathway where the clinically meaningful information actually lives.

DHEA-S and pregnenolone — compounds the male adrenal and neurological systems are equipped to use effectively, frequently low in men presenting with fatigue and cognitive decline.

Progesterone is not on that list. Not because it was overlooked. Because the male endocrine system wasn't built to use it — and three separate lines of clinical evidence explain what happens when it tries.

The same compound class used clinically to suppress male sexual function is appearing in male hormone optimization protocols. That gap between what the data shows and what some providers prescribe is exactly where patient outcomes get lost.

Is Your Protocol Actually Built for You?

If you're on a hormone protocol that includes progesterone and you haven't felt optimized, that's worth examining — not as a coincidence, but as a mechanism.

A thorough evaluation looks at the full panel: free testosterone, SHBG, estradiol, thyroid function, DHEA-S, cortisol, and inflammatory markers. From there, the goal is a protocol built around what your physiology is designed to use.

Virtual consultations are available and the first conversation is free. Bring your labs if you have them. The goal is a straight answer about whether your protocol is actually working for you — or against you.

References

1. Zitzmann M, Erren M, Kamischke A, Simoni M, Nieschlag E. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab. 2005 Dec;90(12):6603–8. — PMID: 16204370

2. Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab. 1996 Nov;81(11):4113–21. — PMID: 8923869

3. Cooper AJ. Progestogens in the treatment of male sex offenders: a review. Can J Psychiatry. 1986 Feb;31(1):73–9. — PMID: 2936441

[DISCLAIMER]

This content is for educational purposes only and does not constitute medical advice. Hormone therapy involves individualized clinical evaluation and is not appropriate for everyone. Always consult a qualified healthcare provider before starting, stopping, or modifying any hormone protocol.

What Is Bioidentical Hormone Replacement Therapy — and Is It Right for You?

The term “bioidentical” gets used loosely, and that creates genuine confusion about whether bioidentical hormone replacement therapy (BHRT) is meaningfully different from conventional hormone therapy or just well-packaged marketing. It’s a fair question. BHRT is a legitimate clinical approach with a defined pharmacological basis and a growing body of supporting evidence — but it requires proper evaluation, individualized dosing, and ongoing monitoring to do responsibly. Here’s what it actually is, how the key hormones are used, and how to think about whether it belongs in your care.

What “Bioidentical” Actually Means — and Why It Matters

Bioidentical hormones are molecularly identical to those the human body produces. Bioidentical estradiol has the same chemical structure as the estradiol your ovaries make; bioidentical testosterone matches what your testes or adrenal glands produce. Conventional hormone therapies often use synthetic compounds that are structurally similar but not identical — medroxyprogesterone acetate and conjugated equine estrogens being the most familiar examples. These compounds bind hormone receptors, but in ways the body wasn’t designed for. That mismatch is what drives the risks and side effects associated with synthetic hormones: increased clotting risk, adverse cardiovascular effects, and elevated breast cancer risk.

The distinction is most clinically significant for progesterone. Synthetic progestins increase the risk of blood clots and breast cancer. Bioidentical progesterone does neither — evidence suggests it actively reduces breast cancer risk. Conflating the two has caused unnecessary confusion and led many women to avoid hormone therapy that could genuinely help them. Bioidentical hormones interact with receptors the way the body expects. That difference in mechanism is the difference in risk profile.

Synthetic hormones carry risks because they bind receptors in ways the body wasn’t designed for. Bioidentical hormones don’t carry those same risks — because the body is designed to receive them.

The Hormones — What They Do and How They’re Used

BHRT is a personalized protocol built around individual lab findings and symptoms, not a single prescription. The hormones most commonly addressed are the following.

Testosterone — Men

Testosterone peaks in the mid-twenties and declines roughly 1 to 2% per year after thirty. By the time most men seek evaluation, they’ve been living with the downstream effects for years: fatigue, reduced drive, difficulty maintaining muscle, increased abdominal fat, disrupted sleep, and diminished libido. Treatment is delivered as a topical cream or injection. Cream produces more stable day-to-day levels and generates higher DHT — the more potent androgen driving libido, muscle, and energy — but requires consistent daily application. Injections eliminate absorption variability and suit patients who prefer a less frequent routine, though levels fluctuate more between doses. The right choice depends on the patient’s lifestyle and clinical profile.

Testosterone — Women

Testosterone is produced by the ovaries and adrenal glands in women and plays a central role in energy, libido, cognitive function, muscle tone, and mood. Levels begin declining in a woman’s thirties — well before menopause — and falling testosterone and progesterone are often the earliest hormonal markers of perimenopause, appearing years before estradiol shifts significantly. Delivery is cream or injection, with the same tradeoffs as in men. Topical cream has the added benefit of addressing local vaginal symptoms — dryness, discomfort, reduced sensitivity — alongside systemic effects, making it particularly effective for women managing both dimensions of decline.

Estradiol

Estradiol decline drives the hot flashes and night sweats most people associate with menopause — though perimenopausal hot flashes are more often triggered by loss of inhibin, a hormone that begins declining years before estradiol does. Beyond vasomotor symptoms, estradiol affects bone density, cardiovascular protection, cognitive function, and sleep. Oral estradiol is generally preferred for its favorable impact on lipids and cardiovascular health. For women with elevated clotting risk, transdermal cream is the appropriate alternative. Patches are available on patient request but are not a primary recommendation due to less consistent absorption and the absence of the cardiovascular benefits seen with oral dosing.

Progesterone

Progesterone is often framed as relevant only for women with a uterus. That misses most of its clinical importance. It begins declining in the early-to-mid thirties and its effects extend well beyond uterine protection: sleep quality, anxiety, mood stability, bone strength, cardiovascular health, and protection against breast, uterine, and ovarian cancers — benefits that apply regardless of surgical history. Oral micronized progesterone is preferred; its mild sedative quality taken at night is frequently therapeutic. For patients sensitive to that effect, a rapid-dissolving sublingual tablet achieves equivalent blood levels with less sedation.

Thyroid

Standard levothyroxine provides T4 only, but T4 must convert to the active T3 form in peripheral tissues — a process that can be impaired even when TSH is normal. Desiccated thyroid extract (DTE), which contains both T4 and T3 in a physiologically relevant ratio, is the primary approach used here. Compounded T3/T4 combination therapy serves as an alternative when DTE isn’t the right fit. Both require careful titration and ongoing monitoring of Free T3 and Free T4.

No two patients look exactly alike. The protocol that works is the one built around your specific labs, symptoms, and history — not a standardized template.

Off-Label Use, Compounding, and Monitoring

Most bioidentical hormones used in BHRT are compounded by a licensed pharmacy, allowing for individualized dosing and delivery forms unavailable in standard commercial products. Compounded preparations are not FDA-approved as finished drug products, but the active ingredients are FDA-regulated and compounding pharmacies operate under state pharmacy board oversight. BHRT is off-label not because the hormones are unproven, but because the FDA approval pathway is designed for standardized products, not individualized therapy.

What this requires clinically is structured monitoring. Every protocol begins with a comprehensive baseline evaluation. Symptom check-ins follow every one to two months; labs run approximately every three months initially, then less frequently once stable. Contraindications — including hormone-sensitive cancers, certain clotting disorders, and uncontrolled cardiovascular disease — are evaluated individually before any therapy begins.

What This Looks Like in Practice

A 52-year-old postmenopausal patient came in after two years of managing hot flashes with over-the-counter supplements. She wasn’t sleeping, her energy and mental clarity had declined significantly, and she’d attributed it to aging. Her physician had offered a standard estrogen patch but hadn’t measured testosterone or progesterone.

Baseline labs showed low estradiol, undetectable testosterone, progesterone below any meaningful range, and a Free T3 at the low end of the reference interval despite a normal TSH. We built a protocol around oral estradiol, oral micronized progesterone, low-dose testosterone cream, and desiccated thyroid extract. Sleep improved substantially by month three. By month six to seven, her energy, cognitive clarity, and overall wellbeing were meaningfully restored — the result of a complete evaluation and a protocol built around her specific picture, not a template.

Is BHRT Right for You?

BHRT is worth exploring if you’re experiencing fatigue, cognitive fog, disrupted sleep, mood changes, loss of muscle tone, reduced libido, or poor recovery — and either haven’t had a comprehensive hormone evaluation or have been told your labs are normal without a deeper conversation. It’s also worth exploring if you’ve been on conventional hormone therapy and still don’t feel right. Synthetic and bioidentical hormones are not the same thing, and the distinction has real clinical implications. The starting point is always a thorough evaluation, not an assumption that treatment is indicated before the full picture is clear.

Start with a Conversation

If any of this resonates, a free consultation is a reasonable next step — not a commitment to anything, just an opportunity to talk through what you’re experiencing and whether a comprehensive evaluation makes sense. Virtual consultations are available through the Precision Hormone Consulting website. To schedule in person, call the clinic directly.

Medical Disclaimer: The content in this post is intended for general educational purposes only and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Bioidentical hormone replacement therapy involves compounded and off-label medications that require individualized assessment, physician oversight, and ongoing monitoring. Hormone therapy is not appropriate for everyone. Contraindications exist and must be evaluated on an individual basis by a qualified healthcare provider. Always consult a physician regarding your specific symptoms, history, and treatment options before initiating any hormone therapy.